Big Machine Racing signs Will Rodgers to drive the #48 Chevrolet for the 2027 NASCAR O’Reilly Autoparts Series season.
MIAMI, FL – November 7, 2026 – After a limited three race partnership in Phoenix, Talladega, and this weekend at Homestead-Miami Speedway, Will Rodgers will move to full time next year for Big Machine Racing.
"Will brings experience, talent, speed, and focus that are undeniable to Big Machine Racing,” says owner Scott Borchetta. "His character and work ethic align perfectly with us. We have tremendous confidence in his future and believe he is the right driver to lead this team into its next chapter."
“I’m thrilled to be joining Big Machine Racing full-time in 2027,” says Rodgers. "It’s been a long time coming and a tremendous amount of work to develop the opportunity to run a full season in the O’Reilly Series, and I can’t thank Scott Borchetta and Patrick Donahue enough for trusting me to represent the #48 car.”
"This, of course, wouldn’t be possible without an amazing group of people behind me, including my team at the Will Rodgers Liver Health Foundation and our core partners, Boehringer Ingelheim and Echosens,” continues Will. “I’m looking forward to representing BMR, the #48 car and our campaign, Driving Good Health.”
Driving Good Health is a liver-health education and awareness program created by the Will Rodgers Liver Health Foundation in partnership with Boehringer Ingelheim. The initiative aims to increase awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), improve access to education and help connect people with appropriate health resources. MASLD happens when excess fat builds up in the liver; its more serious form, MASH, adds inflammation and damage. MASLD affects about 24% of U.S. adults.
Through fan experiences and community activations, Driving Good Health encourages people to learn about their liver health and understand their risk factors for liver disease. Learn more here: Home — Will Rodgers Liver Health Foundation
About Big Machine Racing
Big Machine Racing is owned by music mogul Scott Borchetta, the multi award-winning record executive, President/CEO and Founder of Nashville based Big Machine Label Group, Borchetta Entertainment Group and Big Machine Distilleries. Since its beginning in 2021, The Welcome, North Carolina based team has proven its ability with multiple Top 5 and top 10 finishes, the team’s first win at the Texas Motor Speedway in 2022, a second win at Atlanta in 2025 and making the playoffs in 2023, 2024 and 2025.
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com/us.
About Echosens
A pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan®, the non-invasive solution for comprehensive management of liver health. FibroScan® is recognized worldwide and validated by more than 5,600 peer-reviewed publications, including nearly 220 international guidelines. https://www.echosens.com/Overview
Team website and socials
https://www.instagram.com/bigmachineracing
https://twitter.com/bigmchnracing
https://www.facebook.com/bigmachineracing
About Big Machine Racing:
Big Machine Racing is owned by music mogul Scott Borchetta, the multi award-winning record executive, President/CEO and Founder of Nashville based Big Machine Label Group and Big Machine Distilleries. The team made the playoffs in 2023, 2024 and 2025.